Healthcare & Biotech
Ochre Bio
RNA medicines for liver diseases
Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases.
- Therapeutics
- Biotech
- Genomics
- Website
- ochre-bio.com
- Headquarters
- London, England, United Kingdom
- Team size
- 11-50 people
- Founded
- 2020
- Demo
- 30 min demo
Similar companies
Velorum TherapeuticsBreakthrough medicines unlocking the biology of heme
Sensible BiotechnologiesUnlocking the next generation of mRNA medicines
Entelexo BiotherapeuticsCreating a New Class of Drugs to Address Incurable Autoimmune Diseases
Eris BiotechOur drugs engage the immune system to fight tumors
Sequence BioDiscovering the true signals of disease to power life-changing drugs.
AlixiaTargeting the Tumor Ecosystem to address cancer drug resistance.
Equator TherapeuticsWe are developing a drug to burn calories and increase metabolism…
Origami Therapeutics, Inc.Oral drugs to halt neurodegeneration